Page last updated: 2024-11-04

terfenadine and Brain Diseases

terfenadine has been researched along with Brain Diseases in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hawkes, N1
Shukla, R1
Nag, D1
Chandra, A1

Other Studies

2 other studies available for terfenadine and Brain Diseases

ArticleYear
Dogs died in studies of drug that killed man in French trial.
    BMJ (Clinical research ed.), 2016, Feb-29, Volume: 352

    Topics: Animals; Brain; Brain Diseases; Clinical Trials as Topic; Death; Disease Models, Animal; Disease Pro

2016
Terfenadine induced coma mimicking structural brain disease.
    The Journal of the Association of Physicians of India, 1996, Volume: 44, Issue:10

    Topics: Adult; Brain Diseases; Coma; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Male; Terfen

1996